Repression of human thymidylate synthase mRNA translation by antisense 2'-O-methyl oligoribonucleotides

Antisense and Nucleic Acid Drug Development

Volumn 8, Issue 5, 1998, Pages 371-378

  Schmitz, John C ^a   Agrawal, Sudhir ^b   Chu, Edward ^a,c  

^a YALE CANCER CENTER   (United States)

^b HYBRIDON INC   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CIS ACTING ELEMENT; MESSENGER RNA; OLIGORIBONUCLEOTIDE; PROTEIN P53; THYMIDYLATE SYNTHASE;

ARTICLE; ESCHERICHIA COLI; HUMAN; PRIORITY JOURNAL; RABBIT; RETICULOCYTE LYSATE; RNA TRANSLATION;

EID: 0031794562     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1998.8.371     Document Type: Article

References (13)

1. BERNE, M.H., GUSTAVSSON, B.G., ALMERSJO, O., SPEARS, P.C., and FROSING, R. (1986). Sequential methotrexate/5-FU: FdUMP formation and TS inhibition in a transplantable rodent colon adenocarcinoma. Cancer Chemother. Pharmacol. 16, 237-242.
2. BISHOP, M.R., IVERSEN, P.L., BAYEVER, E., SHARP, J.G., GREINER, T.C., COPPLE, B.L., RUDDON, R., ZON, G., SPINOLO, J., ARNESON, M., ARMITAGE, J.O., and KESSINGER, A. (1996). Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies. J. Clin. Oncol. 14, 1320-1326.
3. CARRERAS, C.W., and SANTI, D.V. (1995). The catalytic mechanism and structure of thymidylate synthase. Annu. Rev. Biochem. 64, 721-762.
4. CHU, E., and ALLEGRA, C.J. (1993). Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma. Adv. Ex. Med. Biol. 339, 143-151.
5. CHU, E., and ALLEGRA, C.J. (1996). The role of thymidylate synthase as an RNA binding protein. Bioessays 18, 191-198.
6. CHU, E., COGLIATI, T., COPUR, S.M., BORRE, A., VOELLER, D.M., ALLEGRA, C.J., and SEGAL, S. (1996). Identification of in vivo target RNA sequences bound by thymidylate synthase. Nucleic Acids Res. 24, 3222-3228.
7. CHU, E., KOELLER, D.M., CASEY, J.L., DRAKE, J.C., CHABNER, B.A., ELWOOD, P.C., ZINN, S., and ALLEGRA, C.J. (1991). Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc. Natl. Acad. Sci. USA 88, 8977-8981.
8. CHU, E., TAKECHI, T., JONES, K.L., VOELLER, D.M., COPUR, S.M., MALEY, G.F., MALEY, F., SEGAL, S., and ALLEGRA, C.J. (1995). Thymidylate synthase binds to c-myc RNA in human colon cancer cells and in vitro. Mol. Cell. Biol. 15, 179-185.
9. CHU, E., VOELLER, D., KOELLER, D.M., DRAKE, J.C., TAKIMOTO, C.H., MALEY, G.F., MALEY, F., and ALLEGRA, C.J. (1993). Identification of an RNA binding site for human thymidylate synthase. Proc. Natl. Acad. Sci. USA9 0, 517-521.
10. COHEN, J.S. (1991). Oligonucleotides as therapeutic agents. Pharmacol. Ther. 52, 211-225.
11. WEBB, A., CUNNINGHAM, D., COTTER, F., CLARKE, P.A., DI STEFANO, F., ROSS, P., CORBO. M., and DZIEWANOWSKA, Z. (1997). bcl-2 antisense therapy in patients with non-Hodgkin's lymphoma. Lancet 349, 1137-1141.
12. WICKSTROM, E.L., BACON, T.A., GONZALEZ, A., FREEMAN, D.L., LYMAN, G.H., and WICKSTROM, E. (1988). Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc. Natl. Acad. Sci. USA 85, 1028-1032.
13. WU, H., MacLEOD, A.R., LIMA, W.F., and CROOKE, S.T. (1998). Identification and partial purification of human double strand RNase activity. J. Biol. Chem. 273, 2532-2542.